Fundraising FoxFidelity Investments — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.
BiotechBedford, US
Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)
BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)
Co-investors5AM VenturesARCH Venture PartnersOUP (Osage University Partners)AlexandriaDeerfield Management CompanyHBM Healthcare Investments+5 more
Lyra provides mental health care services through a network of evidence-based providers, combining clinical expertise with technology to deliver accessible, quality care for employers and health plans.
Digital HealthEnterprise SoftwareHealthtechHR TechMental HealthBurlingame, US
David Ebersman(Founder)inBob Kocher(Co-Founder and Board Member)inDena Bravata(Founder)Alethea Varra(Vice President of Clinical Care)inJennifer Schulz(Chief Executive Officer)Elaine Yang(Executive Officer)in
Co-investorsAdditionBreyer CapitalCasdin CapitalCoatue ManagementDragoneer Investment GroupDurable Capital Partners+10 more
Nuvia provides inbound and outbound AI agents that generate, qualify, and convert leads into sales automatically.
AI & Machine LearningSaaSSales Tech
John Pazin
Co-investors1616 VenturesAmador HoldingsCapria VenturesDell Technologies CapitalNXTPAtlantic Bridge Ventures+6 more
SpotOn is a cloud-based restaurant management system and point-of-sale platform for restaurant operators, offering online ordering, reservations, labor management, and AI-powered financial analysis.
Enterprise SoftwareSaaSSan Francisco, US
Doron Friedman(Founder)inMatthew Hyman(Executive Officer, Director)inZachary Hyman(Executive Officer, Director)inRJ Horsley(Executive Officer)inMatt Hyman(Founder)Zach Hyman(Founder)
Co-investorsAndreessen HorowitzDragoneer Investment GroupDST Global01 AdvisorsAurumCoatue Management+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.